[86] described that RG7834, a novel oral HBV gene expression inhibitor, could decrease the amounts of viral proteins and reduce viremia. RG7834 is a little-molecule compound belonging for the dihydroquinolizinones chemical course similar to RNAi but by means of another mechanism.We also shown that AZD4547, administered for ten months in the chance